欧舒丹(00973.HK)急涨15%创逾十个月高 中绩後获花旗及野村升价
欧舒丹(00973.HK)中绩少赚37.5%,花旗调高欧舒丹目标价至19元和维持「买入」评级,以及升公司未来三年盈测,以反映公司较高经营溢利率预期;野村绩後也上调欧舒丹目标价至21.1元及重申「买入」评级,以反映公司利润率前景乐观。该股今天高见19.2元,创逾十个月高,现造18.8元,回升15%,成交额增至1,627万元。
欧舒丹昨天收市後公布,截至9月底止中期纯利按年(下同)减少37.5%至1.561.3万欧元,营业额6.17亿欧元,按报告汇率及固定汇率分别减少15.2%及13.1%;经营溢利减少21.2%至3,290万欧元;毛利跌14.2%至5.06亿欧元,毛利率按年增加0.9个百分点至82.1%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.